Carlo Gambacorti‐Passerini
Active 1986–2025
- Also published as
- Carlo Gambacorti Passerini
- 124
- Papers
- 23,252
- Citations
- 77
- h-index
- 120
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine66.1%
- Biochemistry, Genetics and Molecular Biology28.7%
- Immunology and Microbiology2.4%
- Computer Science0.6%
- Chemistry0.4%
- Pharmacology, Toxicology and Pharmaceutics0.3%
- Other1.5%
Topics
- Chronic Myeloid Leukemia Treatments10.3%
- Acute Myeloid Leukemia Research7.8%
- Chronic Lymphocytic Leukemia Research6%
- Eosinophilic Disorders and Syndromes4.4%
- Myeloproliferative Neoplasms: Diagnosis and Treatment3.1%
- Acute Lymphoblastic Leukemia research2.6%
- Other65.8%
Coauthors
- Jörge E. Cortes28
- Rocco Piazza28
- Luca Mologni26
- Tim H. Brümmendorf22
- Dong‐Wook Kim17
- Hagop M. Kantarjian16
- Eric Leip14
- Andreas Hochhaus13
- Michael W. Deininger13
- Sara Redaelli13
- Philipp le Coutre11
- Elisabetta Abruzzese10
- H. Jean Khoury10
- Vera Magistroni10
- Alessandra Pirola9
- Andrea Aroldi9
- Diletta Fontana9
- Fabio Stagno9
- Geeta G. Sharma9
- Michael J. Mauro9
- Mario Mauri8
- Charles Chuah7
- François Guilhot7
- Laura Antolini7
All papers
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
Authors: Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Sung-Soo Yoon, Peter Ellis, David C. Wedge, Andrea Pellagatti, Adam Shlien, Michael J. Groves, Simon Forbes, Keiran Raine, Jon Hinton, Laura Mudie, Stuart McLaren, Claire Hardy, Calli Latimer, Matteo Giovanni Della Porta, Sarah O’Meara, Ilaria Ambaglio, Anna Gallì, Adam P. Butler, Gunilla Walldin, Jon W. Teague, Lynn Quek, Alex Sternberg, Carlo Gambacorti‐Passerini, Nicholas C.P. Cross, Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 cited by 1,832
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Authors: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 cited by 1,124
- Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
Authors: Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz, Philipp D. le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Stephanie Lustgarten, Victor M. Rivera, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, Neil P. Shah, Hagop M. Kantarjian - Blood 2018 cited by 583
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
Authors: Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood, Luca Malcovati, Paresh Vyas, David Bowen, Andrea Pellagatti, James S. Wainscoat, Eva Hellström‐Lindberg, Carlo Gambacorti‐Passerini, Anna L. Godfrey, Inmaculada Rapado, Ana Cvejic, Richard Rance, Chris McGee, Peter Ellis, Laura Mudie, Philip J. Stephens, Stuart McLaren, Charles Massie, Patrick Tarpey, Ignacio Varela, Serena Nik‐Zainal, Helen Davies, Adam Shlien, David Jones, Keiran Raine, Jonathan Hinton, Adam P. Butler, Jon W. Teague, E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 cited by 1,216
- Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Authors: Jörge E. Cortes, Carlo Gambacorti‐Passerini, Michael W. Deininger, Michael J. Mauro, Charles Chuah, Dong‐Wook Kim, Iryna Dyagil, Nataliia Glushko, Dragana Milojković, Philipp le Coutre, Valentín García‐Gutiérrez, Laurence Reilly, Allison Jeynes-Ellis, Eric Leip, Nathalie Bardy‐Bouxin, Andreas Hochhaus, Tim H. Brümmendorf - Journal of Clinical Oncology 2017 cited by 493
- Integrative pathway enrichment analysis of multivariate omics data
Authors: Marta Paczkowska, Jonathan Barenboim, Nardnisa Sintupisut, Natalie S. Fox, Helen Zhu, Diala Abd-Rabbo, Miles W. Mee, Paul C. Boutros, PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Gary D. Bader, Rameen Beroukhim, Johanna Bertl, Keith A. Boroevich, Søren Brunak, Peter J. Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Priyanka Dhingra, Klev Diamanti, Lars Feuerbach, J. Lynn Fink, Nuno A. Fonseca, Joan Frigola, Carlo Gambacorti‐Passerini, Dale W. Garsed, Mark Gerstein, Gad Getz, Abel González-Pérez, Qianyun Guo, Marta Gut, David Haan, Mark Hamilton, Nicholas J. Haradhvala, Arif Harmanci, Mohamed Helmy, Carl Herrmann, Julian M. Hess, Asger Hobolth, Ermin Hodzic, Chen Hong, Henrik Hornshøj, Keren Isaev, José M. G. Izarzugaza, Rory Johnson, Todd A. Johnson, Malene Juul, Randi Istrup Juul, Andre Kahles, Abdullah Kahraman, Manolis Kellis, Ekta Khurana, Jaegil Kim, Jong K. Kim, Young-Wook Kim, Jan Komorowski, Jan O. Korbel, Sushant Kumar, Andrés Lanzós, Michael S. Lawrence, Shantao Li, Kjong-Van Lehmann, Shantao Li, Xiaotong Li, Ziao Lin, Eric Minwei Liu, Lucas Lochovsky, Shaoke Lou, Tobias Madsen, Kathleen Marchal, Iñigo Martincorena, Alexander Martinez‐Fundichely, Yosef E. Maruvka, Patrick D. McGillivray, William Meyerson, Ferran Muiños, Loris Mularoni, Hidewaki Nakagawa, Morten Muhlig Nielsen, Keunchil Park, Kiejung Park, Jakob Skou Pedersen, Oriol Pich, Tirso Pons, Sergio Pulido-Tamayo, Benjamin J. Raphael, Iker Reyes-Salazar, Matthew A. Reyna, Esther Rheinbay, Mark A. Rubin, Carlota Rubio-Pérez, Radhakrishnan Sabarinathan, S. Cenk Şahinalp, Gordon Saksena, Leonidas Salichos and 1,360 more - Nature Communications 2020 cited by 236
- Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy
Authors: Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti‐Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu - Blood 2022 cited by 126
- Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
Authors: Tim H. Brümmendorf, Jörge E. Cortes, Dragana Milojković, Carlo Gambacorti‐Passerini, Richard E. Clark, Philipp le Coutre, Valentín García‐Gutiérrez, Charles Chuah, Vamsi Kota, Jeffrey H. Lipton, Philippe Rousselot, Michael J. Mauro, Andreas Hochhaus, Rafael Hurtado Monroy, Eric Leip, Simon Purcell, Anne Yver, Andrea Viqueira, Michael W. Deininger, BFORE study investigators - Leukemia 2022 cited by 141
- Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Authors: Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Bingxia Wang, Meliessa Hennessy, Alexander Vorog, Niti Patel, Tammie C. Yeh, Josep‐María Ribera - JAMA 2024 cited by 114
- Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
Authors: Philippe Rousselot, marie Magdelaine Coude, Nicola Gökbuget, Carlo Gambacorti‐Passerini, Sandrine Hayette, Jean‐Michel Cayuela, Françoise Huguet, Thibaut Leguay, Patrice Chevallier, Célia Salanoubat, Caroline Bonmati, Magda Alexis, Mathilde Hunault, Sylvie Glaisner, Philippe Agapé, Christian Berthou, Éric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumédaly Reman, Bruno Lioure, Xavier Thomas, Norbert Ifrah, Mårina Lafage‐Pochitaloff, Anne Bornand, Laure Morisset, Valérie Robin, Heike Pfeifer, André Delannoy, Josep‐María Ribera, Renato Bassan, Marc Delord, Dieter Hoelzer, Hervé Dombret, Oliver G. Ottmann - Blood 2016 cited by 326
- Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Authors: Valentina Zuco, Rosanna Supino, Sabina Carla Righetti, Loredana Cleris, Edoardo Marchesi, Carlo Gambacorti‐Passerini, Franca Formelli - Cancer Letters 2002 cited by 530
- Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option
Authors: Jeffrey H. Lipton, Tim H. Brümmendorf, Carlo Gambacorti‐Passerini, Valentín García‐Gutiérrez, Michael W. Deininger, Jörge E. Cortes - Blood Reviews 2022 cited by 64
- Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
Authors: Joana Carlevaro-Fita, Andrés Lanzós, Lars Feuerbach, Chen Hong, David Mas-Ponte, Jakob Skou Pedersen, PCAWG Drivers and Functional Interpretation Group, Federico Abascal, Samirkumar B. Amin, Gary D. Bader, Jonathan Barenboim, Rameen Beroukhim, Johanna Bertl, Keith A. Boroevich, Søren Brunak, Peter J. Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Priyanka Dhingra, Klev Diamanti, Lars Feuerbach, J. Lynn Fink, Nuno A. Fonseca, Joan Frigola, Carlo Gambacorti‐Passerini, Dale W. Garsed, Mark Gerstein, Gad Getz, Abel González-Pérez, Qianyun Guo, Marta Gut, David Haan, Mark P. Hamilton, Nicholas J. Haradhvala, Arif Harmanci, Mohamed Helmy, Carl Herrmann, Julian M. Hess, Asger Hobolth, Ermin Hodzic, Chen Hong, Henrik Hornshøj, Keren Isaev, José M. G. Izarzugaza, Rory Johnson, Todd A. Johnson, Malene Juul, Randi Istrup Juul, André Kahles, Abdullah Kahraman, Manolis Kellis, Ekta Khurana, Jaegil Kim, Jong K. Kim, Young-Wook Kim, Jan Komorowski, Jan O. Korbel, Sushant Kumar, Andrés Lanzós, Erik G. Larsson, Michael S. Lawrence, Dong-Hoon Lee, Kjong-Van Lehmann, Shantao Li, Xiaotong Li, Ziao Lin, Eric Minwei Liu, Lucas Lochovsky, Shaoke Lou, Tobias Madsen, Kathleen Marchal, Iñigo Martincorena, Alexander Martinez‐Fundichely, Yosef E. Maruvka, Patrick D. McGillivray, William Meyerson, Ferran Muiños, Loris Mularoni, Hidewaki Nakagawa, Morten Muhlig Nielsen, Marta Paczkowska, Keunchil Park, Kiejung Park, Jakob Skou Pedersen, Oriol Pich, Tirso Pons, Sergio Pulido-Tamayo, Benjamin J. Raphael, Jüri Reimand, Iker Reyes-Salazar, Matthew A. Reyna, Esther Rheinbay, Mark A. Rubin, Carlota Rubio-Pérez, Radhakrishnan Sabarinathan, S. Cenk Sahinalp and 1,362 more - Communications Biology 2020 cited by 190
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Authors: Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michèle Cavo, Francesco Merli, Emanuele Angelucci, Mauro Krampera, Roberto Cairoli, Matteo Giovanni Della Porta, Nicola Stefano Fracchiolla, Marco Ladetto, Carlo Gambacorti‐Passerini, Marco Salvini, Monia Marchetti, Roberto M. Lemoli, Alfredo Molteni, Alessandro Busca, Antonio Cuneo, Alessandra Romano, Nicola Giuliani, Sara Galimberti, Alessandro Corso, Alessandro Morotti, Brunangelo Falini, Atto Billio, Filíppo Gherlinzoni, Giuseppe Visani, Maria Chiara Tisi, Agostino Tafuri, Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini - The Lancet Haematology 2020 cited by 554
- SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub
Authors: Rocco Piazza, Vera Magistroni, Sara Redaelli, Mario Mauri, Luca Massimino, Alessandro Sessa, Marco Peronaci, Maciej Łałowski, Rabah Soliymani, Caterina Mezzatesta, Alessandra Pirola, Federica Banfi, Alicia Rubio, Delphine Réa, Fabio Stagno, Emilio Usala, Bruno Martino, Leonardo Campiotti, Michele Merli, Francesco Passamonti, Francesco Onida, Alessandro Morotti, Francesca Pavesi, Marco Bregni, Vania Broccoli, Marc Baumann, Carlo Gambacorti‐Passerini - Nature Communications 2018 cited by 157
- Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Authors: Andreas Hochhaus, Carlo Gambacorti‐Passerini, Camille N. Abboud, Bjørn Tore Gjertsen, Tim H. Brümmendorf, B. Douglas Smith, Thomas Ernst, Pilar Giraldo-Castellano, Ulla Olsson‐Strömberg, Susanne Saußele, Nathalie Bardy‐Bouxin, Andrea Viqueira, Eric Leip, T. Alexander Russell-Smith, Jocelyn M Leone, Gianantonio Rosti, Justin M. Watts, Francis J. Giles, on behalf of the BYOND Study Investigators, Elisabetta Abruzzese, L Akard, Alberto Bosi, F. Cervantes, Aude Charbonnier, Francesco Di Raimondo, Gabriel Etienne, V. Garcia Gutierrez, Agnès-Paule Guerci-Bresler, Henrik Hjorth‐Hansen, Jean Michel Karsenti, Kevin R. Kelly, P. Le Coutre, Carmen Martínez Chamorro, Vivian G. Oehler, G. Orti Pascual, Andreas Petzer, Ester Pungolino, Giovanna Rege‐Cambrin, Françoise Rigal‐Huguet, Gail J. Roboz, P. Rousselot, Fermín Sánchez‐Guijo, Guillermo Sanz Santillana, Philippe Schafhausen, C. Scheid, Stefan Schmidt, Giorgina Specchia, Juan Luis Steegmann, Leif Stenke - Leukemia 2020 cited by 83
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Authors: Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus, François Guilhot, Charles A. Schiffer, Carlo Gambacorti‐Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, Moshe Talpaz, Brian Druker - New England Journal of Medicine 2002 cited by 2,030
- Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Authors: Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf, Dong‐Wook Kim, Anna Turkina, Zhi-Xiang Shen, Ricardo Pasqüini, H. Jean Khoury, Steven Arkin, Angela Volkert, Nadine Besson, Richat Abbas, Junyuan Wang, Eric Leip, Carlo Gambacorti‐Passerini - Blood 2011 cited by 461
- Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Authors: H. Jean Khoury, Jörge E. Cortes, Hagop M. Kantarjian, Carlo Gambacorti‐Passerini, Michele Baccarani, Dong‐Wook Kim, Andrey Zaritskey, Athena Countouriotis, Nadine Besson, Eric Leip, Virginia Kelly, Tim H. Brümmendorf - Blood 2012 cited by 318
- Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
Authors: Jörge E. Cortes, Dong‐Wook Kim, Hagop M. Kantarjian, Tim H. Brümmendorf, Iryna Dyagil, Laimonas Griškevičius, Hemant Malhotra, Christine Powell, Karı̈n Gogat, Athena Countouriotis, Carlo Gambacorti‐Passerini - Journal of Clinical Oncology 2012 cited by 469
- Pathway and network analysis of more than 2500 whole cancer genomes
Authors: Matthew A. Reyna, David Haan, Marta Paczkowska, Lieven P. C. Verbeke, Miguél Vázquez, Abdullah Kahraman, Sergio Pulido-Tamayo, Jonathan Barenboim, Lina Wadi, Priyanka Dhingra, Raunak Shrestha, Gad Getz, Michael S. Lawrence, Jakob Skou Pedersen, Mark A. Rubin, David A. Wheeler, Søren Brunak, José M. G. Izarzugaza, Ekta Khurana, Kathleen Marchal, Christian von Mering, S. Cenk Şahinalp, Alfonso Valencia, PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Gary D. Bader, Pratiti Bandopadhayay, Rameen Beroukhim, Johanna Bertl, Keith A. Boroevich, John Busanovich, Peter J. Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Klev Diamanti, Lars Feuerbach, J. Lynn Fink, Nuno A. Fonseca, Joan Frigola, Carlo Gambacorti‐Passerini, Dale W. Garsed, Mark Gerstein, Qianyun Guo, Marta Gut, Mark P. Hamilton, Nicholas J. Haradhvala, Arif Harmanci, Mohamed Helmy, Carl Herrmann, Julian M. Hess, Asger Hobolth, Ermin Hodzic, Chen Hong, Henrik Hornshøj, Keren Isaev, Rory Johnson, Todd A. Johnson, Malene Juul, Randi Istrup Juul, André Kahles, Manolis Kellis, Jaegil Kim, Jong K. Kim, Youngwook Kim, Jan Komorowski, Jan O. Korbel, Sushant Kumar, Andrés Lanzós, Erik Larsson, Donghoon Lee, Kjong-Van Lehmann, Shantao Li, Xiaotong Li, Ziao Lin, Eric Minwei Liu, Lucas Lochovsky, Shaoke Lou, Tobias Madsen, Iñigo Martincorena, Alexander Martinez‐Fundichely, Yosef E. Maruvka, Patrick D. McGillivray, William Meyerson, Ferran Muiños, Loris Mularoni, Hidewaki Nakagawa, Morten Muhlig Nielsen, Keunchil Park, Kiejung Park, Tirso Pons, Iker Reyes-Salazar, Esther Rheinbay, Carlota Rubio-Pérez, Gordon Saksena, Leonidas Salichos and 1,354 more - Nature Communications 2020 cited by 115
- Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
Authors: Elif Karaca Atabay, Carmen Mecca, Qi Wang, Chiara Ambrogio, Inês Mota, Nina Prokoph, Giulia Mura, Cinzia Martinengo, Enrico Patrucco, Giulia C. Leonardi, Jessica Hossa, Achille Pich, Luca Mologni, Carlo Gambacorti‐Passerini, Laurence Brugières, Birgit Geoerger, Suzanne D. Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle - Blood 2021 cited by 49
- Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study
Authors: Carlo Gambacorti‐Passerini, Sergey Orlov, Li Zhang, Fadi Braiteh, Huiqiang Huang, Taito Esaki, Keizo Horibe, Jin‐Seok Ahn, J. Thaddeus Beck, W. Jeffrey Edenfield, Yuankai Shi, Matthew H. Taylor, Kenji Tamura, Brian A. Van Tine, Shang‐Ju Wu, Jolanda Paolini, Paulina Selaru, Tae Min Kim - American Journal of Hematology 2018 cited by 110
- Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making
Authors: Ivan Civettini, Arianna Zappaterra, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Stefano Bonfanti, Federica Colombo, Marilena Fedele, Giovanni Grillo, Matteo Parma, Paola Perfetti, Elisabetta Terruzzi, Carlo Gambacorti‐Passerini, Daniele Ramazzotti, Fabrizio Cavalca - British Journal of Haematology 2023 cited by 16
